High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma

Takagi,Keiko; Takayama,Tadatoshi; Nagase,Hiroki; Moriguchi,Masamichi; Wang,Xiaofei; Hirayanagi,Kaname; Suzuki,Tsukasa; Hasegawa,Hiromasa; Ochiai,Takanaga; Yamaguchi,Nobuhisa; Kochi,Mitsugu; Kimura,Makoto; Esumi,Mariko

doi:10.3892/etm.2011.236

High TSC22D3 and low GBP1 expression in the liver is a risk factor for early recurrence of hepatocellular carcinoma

Authors:
- Keiko Takagi
- Tadatoshi Takayama
- Hiroki Nagase
- Masamichi Moriguchi
- Xiaofei Wang
- Kaname Hirayanagi
- Tsukasa Suzuki
- Hiromasa Hasegawa
- Takanaga Ochiai
- Nobuhisa Yamaguchi
- Mitsugu Kochi
- Makoto Kimura
- Mariko Esumi
View Affiliations

Affiliations: Department of Digestive Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan, Department of Cancer Genetics, Nihon University School of Medicine, Tokyo 173-8610, Japan, Department of Hygiene, Nihon University School of Medicine, Tokyo 173-8610, Japan, Department of Oral Pathology, Matsumoto Dental University, Nagano 399-0781, Japan, Department of Pathology, Nihon University School of Medicine, Tokyo 173-8610, Japan
Published online on: March 21, 2011 https://doi.org/10.3892/etm.2011.236
Pages: 425-431

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Recurrence after liver resection for hepatocellular carcinoma (HCC) is a major clinical problem, and prognostic markers for recurrence are urgently required. For 390 HCC cases, segmented linear regression analysis with two segments was performed, and the interval for the early and late recurrence groups was partitioned at the crosspoint (676 days). We investigated whether gene expression in non-tumorous tissues of remnant liver from 39 hepatitis C virus-positive HCC cases may be associated with early recurrence of this disease. By microarray analysis, 21 genes were identified as candidate recurrence-associated genes. Further gene expression analysis was performed, and the localization and expression of the gene products of these candidate genes were immunohisto-chemically evaluated. Low expression of the GBP1 gene and high expression of the TSC22D3 gene were significantly (both P=0.04) associated with the risk of early recurrence. Through backward step-wise multivariate logistic regression analysis for the 21 candidate genes, high expression of GBP1 reduced [odds ratio (OR)=0.20; 95% confidence interval (CI) 0.06-0.73, P=0.02] and high expression of TSC22D3 increased the risk of early recurrence (OR=19.6; 95% CI 1.14‑337.2; P=0.04). Immunohistochemical analysis revealed that hepatocytes showed strong membranous expression for GBP1 in the late recurrence group, but weak membranous expression for GBP1 in the early recurrence group. TSC22D3 was frequently expressed in lymphocytes and in a few hepatocytes in tissues of the early recurrence group. Our observations suggest that the combination of the high expression of the TSC22D3 gene and low expression of the GBP1 gene in the non-tumorous tissue of the remnant liver is significantly associated with early recurrence after surgical resection of HCC.

View Figures

View References

1.	Ikai I, Arii S, Okazaki M, et al: Report of the 17th Nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res. 37:676–691. 2007. View Article : Google Scholar : PubMed/NCBI
2.	Makuuchi M, Takayama T, Kubota K, et al: Hepatic resection for hepatocellular carcinoma – Japanese experience. Hepatogastroenterology. 45(Suppl 3): 1267–1274. 1998.
3.	Imamura H, Matsuyama Y, Tanaka E, et al: Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 38:200–207. 2003. View Article : Google Scholar
4.	Poon RT, Fan ST, Ng IO, Lo CM, Liu CL and Wong J: Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 89:500–507. 2000. View Article : Google Scholar : PubMed/NCBI
5.	Honda M, Kaneko S, Kawai H, Sirota Y and Kobayashi K: Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology. 120:955–966. 2001. View Article : Google Scholar : PubMed/NCBI
6.	Okabe H, Satoh S, Kato T, et al: Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 61:2129–2137. 2001.
7.	Iizuka N, Oka M, Yamada-Okabe H, et al: Differential gene expression in distinct virologic types of hepatocellular carcinoma: association with liver cirrhosis. Oncogene. 22:3007–3014. 2003. View Article : Google Scholar : PubMed/NCBI
8.	Sobin LH and Wittekind C: TNM Classification of Malignant Tumours (UICC). 6th edition. Wiley-Liss; New York: pp. 81–83. 2002
9.	Hosida Y, Villanueva A, Kobayashi M, et al: Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med. 359:2045–2047. 2008.PubMed/NCBI
10.	Tsuchiya M, Parker JS, Kono H, Matsuda M, Fujii H and Rusyn I: Gene expression in nontumoral liver tissue and recurrence-free survival in hepatitis C virus-positive hepatocellular carcinoma. Mol Cancer. 9:742010. View Article : Google Scholar : PubMed/NCBI
11.	Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N and Nakajima Y: Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg. 89:57–62. 2002. View Article : Google Scholar
12.	Wakai T, Shirai Y, Yokoyama N, Nagakura S and Hatakeyama K: Hepatitis virus status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur J Surg Oncol. 29:266–271. 2003. View Article : Google Scholar
13.	Shah SA, Cleary SP, Wei AC, et al: Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 141:330–339. 2007. View Article : Google Scholar : PubMed/NCBI
14.	Regimbeau JM, Abdalla EK, Vauthey JN, et al: Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 85:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
15.	Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M and Makuuchi M: α-fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study. Hepatology. 35:853–860. 2002.
16.	Chen JY, Chau GY, Lui WY, Tsay SH, King KL and Wu CW: Clinicopathologic features and factors related to survival of patients with small hepatocellular carcinoma after hepatic resection. World J Surg. 27:294–298. 2003. View Article : Google Scholar
17.	Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K and Sugimachi K: Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology. 14:802–805. 1991. View Article : Google Scholar
18.	Guenzi E, Töpolt K, Lubeseder-Martellato C, et al: The guanylate binding protein-1 GTPase controls the invasive and angiogenic capability of endothelial cells through inhibition of MMP-1 expression. EMBO J. 15:3772–3782. 2003. View Article : Google Scholar
19.	Guenzi E, Töpolt K, Cornali E, et al: The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines. EMBO J. 20:5568–5577. 2001. View Article : Google Scholar : PubMed/NCBI
20.	Llovet JM, Chen Y, Wurmbach E, et al: A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis. Gastroenterology. 131:1758–1767. 2006. View Article : Google Scholar
21.	Smith MW, Yue ZN, Geiss GK, et al: Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma. Cancer Res. 63:859–864. 2003.PubMed/NCBI
22.	Itsui Y, Sakamoto N, Kurosaki M, et al: Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat. 13:690–700. 2006. View Article : Google Scholar
23.	Naschberger E, Croner RS, Merkel S, et al: Angiostatic immune reaction in colorectal carcinoma: impact on survival and perspectives for antiangiogenic therapy. Int J Cancer. 123:2120–2129. 2008. View Article : Google Scholar
24.	Redjimi N, Gaudin F, Touboul C, et al: Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer. Mol Cancer. 8:832009. View Article : Google Scholar
25.	Wu XZ, Xie GR and Chen D: Hypoxia and hepatocellular carcinoma: the therapeutic target for hepatocellular carcinoma. J Gastroen Hepatol. 22:1178–1182. 2007. View Article : Google Scholar : PubMed/NCBI
26.	Yasui M, Yamamoto H, Ngan CY, et al: Antisense to cyclin D1 inhibits vascular endothelial growth factor – stimulated growth of vascular endothelial cells: implication of tumor vascularization. Clin Cancer Res. 12:4720–4729. 2006.